<DOC>
	<DOCNO>NCT01697930</DOCNO>
	<brief_summary>This Phase I study . This study first time new experimental drug call 18FFluoroglutamine , F-Glutamine , use people . F-Glutamine drug design use PET scanner 'see ' F-Glutamine go body , inject . PET scanners one kinds scanner normally find hospital radiology department . The researcher find tumor animal absorb F-Glutamine . The researcher believe scan F-Glutamine might able find tumors patient . This first in-human study do see long F-Glutamine last blood , give people tiny amount injection , see F-Glutamine go body . If result trial good , study doctor plan use F-Glutamine another trial see scan F-Glutamine well find tumor compare standard type scan doctor use .</brief_summary>
	<brief_title>A Phase I Study : PET Imaging Cancer Patients Using 18F 4-L-Fluoroglutamine ( 2S,4R )</brief_title>
	<detailed_description />
	<criteria>Patients history histologicallyconfirmed solid malignancy and/or lymphoma ( histology confirm MSKCC Department Pathology . ) Disease measurable evaluable define RECIST 1.1 tumor response criterion MSKCC IRBapproved clinical research protocol . NOTE : Study patient need participate MSKCC approve clinical trial prior study recruitment . Age 2190 Negative serum pregnancy test female patient childbearing age potential ( define MSKCC Standards &amp; Guidelines ) , assay obtain &lt; 2 week prior study enrollment . Patients advise unprotected sexual intercourse time negative serum pregnancy test complete participation study . Inability refusal least one peripheral intravenous line intravenous access ( applicable day [ 18F ] 4LFluoroglutamine ( 2S,4R ) injection blood draw . ) Breastfeeding Refusal inability tolerate scanning procedure ( e.g. , due claustrophobia ) Hepatic : assay obtain &lt; 2 week prior study enrollment For patient , upper limit normal ( ULN ) value particular assay define normal reference value laboratory perform assay . Bilirubin &gt; 1.5 x ( ULN ) AST/ALT &gt; 2.5 x ULN Albumin &lt; 3 g/dl GGT &gt; 2.5 x ULN IF Alkaline phosphatase &gt; 2.5 x ULN . Renal : Creatinine &gt; 1.5 x ULN creatinine clearance &lt; 60 mL/min , assay obtain &lt; 2 week prior study enrollment Acute major illness ( e.g. , unstable cardiovascular condition , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>PET Imaging</keyword>
	<keyword>18F ] 4-L-Fluoroglutam ( 2S,4R )</keyword>
	<keyword>12-168</keyword>
</DOC>